Ocugen Ownership | Who Owns Ocugen?
Ocugen Ownership Summary
Ocugen is owned by 45.74% institutional investors, 1.68% insiders, and 52.58% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.43% of OCGN shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 4.06% of its assets in Ocugen shares.
OCGN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ocugen | 45.74% | 1.68% | 52.58% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 27.00M | 8.43% | $41.31M |
| Blackrock | 17.92M | 6.97% | $27.78M |
| State street | 21.47M | 6.70% | $32.85M |
| Vanguard group | 16.48M | 5.42% | $22.24M |
| Vanguard capital management | 14.37M | 4.49% | $21.99M |
| Millennium management | 13.94M | 4.35% | $21.33M |
| Geode capital management | 8.87M | 2.77% | $13.58M |
| Rtw investments, lp | 6.67M | 2.08% | $10.20M |
| Ubs group | 5.18M | 1.62% | $7.92M |
| Ikarian capital | 3.96M | 1.24% | $6.06M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ikarian capital | 3.96M | 0.65% | $6.06M |
| Gmt capital | 3.51M | 0.28% | $5.36M |
| Hennion & walsh asset management | 2.83M | 0.12% | $4.33M |
| Aster capital management (difc) | 398.07K | 0.09% | $386.29K |
| Rtw investments, lp | 6.67M | 0.09% | $10.20M |
| Headlands | 511.57K | 0.08% | $782.71K |
| Silverback asset management | 250.00K | 0.04% | $382.50K |
| Lanham o'dell & company | 100.00K | 0.04% | $135.00K |
| Diadema partners lp | 200.00K | 0.04% | $306.00K |
| Cora capital advisors | 89.22K | 0.04% | $136.51K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 27.00M | 0.00% | 19.70M |
| Blackrock | 17.92M | 0.00% | 14.12M |
| State street | 21.47M | 0.00% | 11.80M |
| Geode capital management | 8.87M | 0.00% | 4.64M |
| Northern trust | 2.75M | 0.00% | 2.03M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Marshall wace, llp | 3.41M | 0.00% | -4.64M |
| Jane street group | - | - | -3.68M |
| Altium capital management lp | - | - | -2.35M |
| Ubs group | 5.18M | 0.00% | -2.10M |
| Citadel advisors | 783.32K | 0.00% | -2.03M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sixth street partners management company | 1.04M | 0.00% | 1.04M | $1.60M |
| Nuveen | 823.46K | 0.00% | 823.46K | $1.26M |
| Aster capital management (difc) | 398.07K | 0.09% | 398.07K | $386.29K |
| Rhumbline advisers | 340.49K | 0.00% | 340.49K | $520.95K |
| Deutsche bank ag\ | 337.90K | 0.00% | 337.90K | $517.00K |
Sold Out
| Holder | Change |
|---|---|
| Psi advisors | -1.00 |
| Chris bulman | -13.00 |
| Nbt bank n a /ny | -50.00 |
| Huntington national bank | -100.00 |
| Strategic investment solutions, inc. /il | -125.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 157 | 7.53% | 146,574,569 | 32.29% | 45 | 3.83% | 91 | 1.11% | 30 | 42.86% |
| Mar 31, 2026 | 143 | 23.28% | 109,433,421 | 79.84% | 35 | 8.74% | 87 | 42.62% | 22 | 10.00% |
| Dec 31, 2025 | 52 | -49.51% | 36,188,300 | -21.17% | 11 | 4.82% | 25 | -34.21% | 9 | -75.68% |
| Sep 30, 2025 | 35 | -67.89% | 17,195,153 | -66.71% | 5 | 1.88% | 9 | -85.25% | 11 | -54.17% |
| Jun 30, 2025 | 109 | -5.22% | 51,825,743 | -32.44% | 17 | 2.57% | 62 | 16.98% | 23 | -25.81% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 13.77M | 4.06% | 31.62K |
| Vanguard US Total Market Shares ETF | 9.07M | 3.11% | - |
| Vanguard Total Stock Mkt Idx Inv | 10.18M | 3.01% | 375.10K |
| Vanguard Morn Total Stk Mkt Idx Investor | 10.18M | 3.01% | 375.10K |
| Vanguard MStar Total Stk Mkt Idx Invest | 10.18M | 3.00% | - |
| SPDR® S&P Biotech ETF | 8.70M | 2.99% | 123.82K |
| iShares Russell 2000 ETF | 8.53M | 2.52% | -151.49K |
| Vanguard Institutional Extnd Mkt Idx Tr | 3.89M | 1.15% | 8.24K |
| Fidelity Small Cap Index | 2.95M | 1.01% | - |
| Russell 2000 Index Non-Lendable Fund | 2.25M | 0.66% | 2.25M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Johnson-Greene Treerita Essalima | Chief Financial Officer | Buy | $25.83K |
| Nov 26, 2024 | Fernandes Prabhavathi | - | Buy | $9.10K |
| Nov 22, 2024 | Castillo Kirsten | - | Buy | $22.85K |
| Jun 14, 2023 | Zhang Junge | - | Buy | $100.00K |
| Feb 16, 2023 | Musunuri Shankar | Chief Executive Officer | Sell | $108.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | 1 | - |
| 2026 Q1 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | 2 | - |
OCGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools